Discontinued — last reported Q4 '25
Total Equity
EquityEli Lilly Total Equity increased by 11.3% to $26.54B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 87.0%, from $14.19B to $26.54B. Over 5 years (FY 2020 to FY 2025), Total Equity shows an upward trend with a 36.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase typically signals strong profitability and retained earnings growth, while a decrease may indicate aggressive share buybacks, dividends, or net losses.
Detailed definition
Total stockholders' equity represents the residual interest in the company's assets after deducting all liabilities, ref...
Peer comparison
Peer technology firms like Apple or Alphabet often show high equity balances driven by massive retained earnings, though these are frequently offset by large-scale share repurchase programs.
total_stockholders_equityHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.66B | $7.95B | $8.98B | $9.46B | $8.66B | $10.17B | $10.65B | $11.29B | $11.15B | $11.31B | $10.77B | $12.90B | $13.64B | $14.32B | $14.19B | $15.85B | $18.35B | $23.85B | $26.54B |
| QoQ Change | — | +19.4% | +12.9% | +5.4% | -8.5% | +17.4% | +4.8% | +6.1% | -1.3% | +1.4% | -4.7% | +19.7% | +5.7% | +5.0% | -0.9% | +11.7% | +15.8% | +30.0% | +11.3% |
| YoY Change | — | — | — | — | +29.9% | +27.8% | +18.6% | +19.4% | +28.8% | +11.2% | +1.1% | +14.2% | +22.3% | +26.6% | +31.8% | +22.9% | +34.6% | +66.5% | +87.0% |
Total Equity at Other Companies
Frequently Asked Questions
- What is Eli Lilly's total equity?
- Eli Lilly (LLY) reported total equity of $26.54B in Q4 2025.
- How has Eli Lilly's total equity changed year-over-year?
- Eli Lilly's total equity increased by 87.0% year-over-year, from $14.19B to $26.54B.
- What is the long-term trend for Eli Lilly's total equity?
- Over 5 years (2020 to 2025), Eli Lilly's total equity has grown at a 36.3% compound annual growth rate (CAGR), from $5.64B to $26.54B.
- What does total equity mean?
- The total value of the company that belongs to the shareholders after all debts have been paid.